PEP - PepsiCo, Inc.
| Previous Close | 132.73 |
| Open | 132.72 |
| Bid | 132.36 x 900 |
| Ask | 132.52 x 2200 |
| Day's Range | 131.88 - 133.24 |
| 52 Week Range | 104.53 - 134.71 |
| Volume | 2,095,428 |
| Avg. Volume | 4,318,682 |
| Market Cap | 185.769B |
| Beta (3Y Monthly) | 0.54 |
| PE Ratio (TTM) | 14.96 |
| EPS (TTM) | 8.86 |
| Earnings Date | Jul 9, 2019 |
| Forward Dividend & Yield | 3.82 (2.98%) |
| Ex-Dividend Date | 2019-06-06 |
| 1y Target Est | 127.84 |
- InvestorPlace•13 hours ago
NBEV Stock Is More Than Just CBD — But It’s Still Not Enough
In a frothy market you can get a mighty high multiple if you're in the right niche. Like marijuana. That's the story of New Age Beverages (NASDAQ:NBEV). NBEV stock tripled last September after announcing a drink containing CBD. Its drinks even have a picture of the late Bob Marley on them.But pot isn't NBEV's real business. Canned beverages are its business. Things like coffee, tea and kombucha. Sodas with strange combinations like watermelon and coconut, the kind of stuff you'll try at a soda ranch on Route 66.InvestorPlace - Stock Market News, Stock Advice & Trading TipsSince that September explosion, where it briefly traded at almost $9, NBEV stock has lost its fizz, settling into a trading range of between $4-6 per share. But its market cap, $350 million, remains impressive for a drinks company with March quarter sales of $58 million, and no profit.But still. Pot! What NBEV Is Up ToNew Age Beverages has used its moment in the pot limelight to bulk up the product line. The highlight was this month's purchase of Brands Within Reach, for $6.4 million, only $500,000 of it cash. * 7 Top-Rated Biotech Stocks to Invest In Today Brands Within Reach has brand licensing and distribution rights for some mainstream beverages, like cold Nestea and Illy coffee. The idea is that this gets New Age in the door at mainstream retailers like Walmart (NYSE:WMT) and Costco Wholesale (NASDAQ:COST), which then might look at its more esoteric brands.This came just six months after buying Morinda Holdings, another small company but with distribution in 60 countries. The idea there was to expand the market for its CBD products.The Morinda combination is already in the numbers due to be reported August 8, where sales of $70.8 million are expected. Following on the first quarter take of $58 million, that's good growth and, if the pattern persists through the year, it could lead to sales equaling the stock's current market cap by this time next year.That's important, because New Beverage CEO Brent Willis knows he's in the drinks business, not the pot business. He promised to focus on execution after buying Morinda, but the chance to buy into serious beverages with just stock was too good to pass up. What Next for NBEV Stock?Some analysts got very bullish on New Age after the Morinda buy, predicting imminent profits and a steady rise to $9 per share, which would be double its current level.InvestorPlace's Josh Enomoto disagrees. He sees the Brands Within Reach acquisition as a turn away from CBD, the source of its frothy valuation. He also sees the current brands as nothing special.Personally, I like the Brands Within Reach deal. NBEV now has both brands that can get it into the door of big retailers and global distribution for its CBD products. But drinks remain a risky business, a land of giants in which NBEV is a mouse. If Coca-Cola (NYSE:KO), Pepsico (NYSE:PEP) or even Keurig Dr Pepper (NYSE:KDP) decided there was something to this CBD thing, they could blow NBEV out of the water quickly. The Bottom Line on NBEV StockI think the owners of Brands Within Reach know all this, so there's an overhang of almost $6 million in stock, itching to be sold right now.Much of the rest of the common stock is held by speculators looking for a quick payout. Institutions hold just over 13% of the common, against almost 26% held by insiders. I think they will bail, too, at the first sign of bad news. * 7 Top-Rated Biotech Stocks to Invest In Today In other words, NBEV stock has a sell-by date, and execution alone won't stave it off.Dana Blankenhorn is a financial and technology journalist. He is the author of the mystery thriller, The Reluctant Detective Finds Her Family, available at the Amazon Kindle store. Write him at danablankenhorn@gmail.com or follow him on Twitter at @danablankenhorn. As of this writing he owned no shares in companies mentioned in this article. Compare Brokers The post NBEV Stock Is More Than Just CBD -- But It's Still Not Enough appeared first on InvestorPlace.
- Investopedia•2 days ago
Coca-Cola vs. Pepsi's Business Models: What's the Difference?
Understand more about the Coca-Cola company and the PepsiCo company. Learn about the key similarities and differences that make both companies successful.
- Benzinga•5 days ago
10 Fleets Sign On To Test Their Fuel Efficiency In NACFE's Run On Less Regional Challenge
After a successful and informative Run on Less in 2017, the North American Council for Freight Efficiency (NACFE) has returned with a new run focusing on fleets running regional routes. The Run on Less Regional event will take place over three weeks in October, beginning October 8 and ending later that month at the North American Commercial Vehicle Show, where NACFE will announce initial results of the run. Ten fleets have signed up for the regional run, including three that also participated in the 2017 long-haul run.
- Evening Standard•6 days ago
Reckitt Benckiser picks Pepsi man Narasimhan to add fizz on £16m pay deal
Consumer giant Reckitt Benckiser named PepsiCo chief Laxman Narasimhan to replace outgoing boss Rakesh Kapoor on Wednesday on an annual pay deal worth around £16 million. The 52-year-old multilingual Indian is Pepsi’s global chief commercial officer, reporting to chief executive Ramon Laguarta. “It is a special company with a long history of outperformance, creating innovative products and iconic brands which improve the health and lives of people across the globe,” said Narasimhan.
- Zacks•6 days ago
Zacks.com featured highlights include: CDW, Bristol-Myers, Celgene, PepsiCo and Northrop
Zacks.com featured highlights include: CDW, Bristol-Myers, Celgene, PepsiCo and Northrop
- Bloomberg•6 days ago
Reckitt Taps Online-Savvy CEO as Cheap Pills Threaten Growth
U.K. grocer J Sainsbury Plc sells a private-label alternative for a third of the price. It was also blindsided by production glitches and slowing sales of infant-nutrition products after acquiring Enfamil maker Mead Johnson. By turning to Narasimhan, a PepsiCo Inc. veteran, the company hopes to reconcile Kapoor’s vision with the reality that fickle shoppers are overwhelmingly turning away from big brands to cheaper alternatives.
- Bloomberg•6 days ago
Reckitt Bets on the Man From Pepsi for Some Fizz
(Bloomberg Opinion) -- Reckitt Benckiser Group Plc has appointed Laxman Narasimhan as its new chief executive officer, succeeding Rakesh Kapoor. An outsider should herald a fresh start for a group that was once a superstar, but has more recently become a laggard.Reckitt has eschewed some of the obvious candidates for the role, such as Tesco Plc’s Dave Lewis or Unilever’s Nitin Paranjpe. It has instead chosen Narasimhan, who joins from PepsiCo Inc., where he was global chief commercial officer.He’s an unknown quantity outside of the U.S. He had a career spanning almost 20 years at McKinsey, before moving to Pepsi. While he was well-regarded there, its change of CEO might have left him as one of the senior executives who missed out on the top job and was therefore looking for opportunities outside of the soft drinks maker.And Reckitt has some particular challenges. It has endured a tumultuous few years, following the $16.6 billion acquisition of Mead Johnson in 2017.Narasimhan should at least bring a burst energy to the group. Kapoor was increasingly worn down by Reckitt’s problems.The first task of the incoming leader is to revive sales expansion, which has stalled. He must also complete the integration of Mead Johnson. It did seem as if it was improving, but hit another bump in the road last year, in the form of disruption to a plant in the Netherlands. Not having been involved in the purchase, Narasimhan can take an impartial view on the best way to tackle what increasingly looks like the wrong deal to have done.Narasimhan must both fit in with Reckitt’s culture, and evolve it. It has a particular hard-driving approach, where cost-cutting to bolster margins is at the forefront. That has gone out of fashion with investors, who want a better balance between top line and bottom line growth. The new CEO will have more scope to warn that margins must come down to facilitate the investment needed to turbocharge sales.Kapoor reorganized Reckitt into two divisions: one focused on household products, such as Cillit Bang cleaner, and the other on consumer health treatments including Nurofen painkillers. As well as being CEO, Narasimhan will directly lead the health arm.But the outgoing CEO hadn't yet taken that to its logical conclusion: separating the two units, possibly through a sale of hygiene and home. While Kapoor had earmarked this as a job for mid-2020, it will fall to his successor to complete the task.A split is not a given: new leaders don’t usually like to take an ax to their empires. There is also a question mark over whether Narasimhan can break up the group, even if he wanted to.As my colleague Chris Hughes has argued, this reinvention could be hampered by the aftershocks from the Justice Department’s indictment of Indivior Plc, the pharma business Reckitt spun off back in 2014. The drugmaker faces a $3 billion fine after U.S. prosecutors alleged it lied about the dangers of its opioid addiction treatment.That Narisimhan didn’t have any hand in the Indivior spin off means he has no baggage associated with the original deal, which would impede finding a solution. Having been based in the U.S., he should also have experience of dealing with regulators there.Indeed, this underlines the benefit of appointing an outsider – to both the company and the broader European consumer goods sector – he has much more latitude to take the difficult decisions that Reckitt needs to regain its stellar status.To contact the author of this story: Andrea Felsted at afelsted@bloomberg.netTo contact the editor responsible for this story: Jennifer Ryan at jryan13@bloomberg.netThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Andrea Felsted is a Bloomberg Opinion columnist covering the consumer and retail industries. She previously worked at the Financial Times.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.
- Reuters•6 days ago
Reckitt picks PepsiCo executive as CEO, going outside for first time
Narasimhan, PepsiCo's global chief commercial officer, is the first external candidate to be appointed as CEO at Reckitt since the maker of Durex condoms, Nurofen tablets and Dettol cleaners was formed in 1999. The 52-year-old takes over as CEO on Sept. 1, replacing Rakesh Kapoor, 60, who has led Reckitt for more than eight years and said in January he would retire this year.
- Reuters•6 days ago
UPDATE 4-Reckitt picks PepsiCo exec as CEO, going outside for first time
Consumer goods group Reckitt Benckiser has picked PepsiCo executive Laxman Narasimhan as its next chief executive, becoming the latest industry heavyweight to turn to a company outsider to tackle faltering growth and new media-savvy rivals. Narasimhan, PepsiCo's global chief commercial officer, is the first external candidate to be appointed as CEO at Reckitt since the maker of Durex condoms, Nurofen tablets and Dettol cleaners was formed in 1999.
- Financial Times•6 days ago
Reckitt Benckiser poaches Pepsi executive for top job
Mr Narasimhan, 52, grew up in India, where he completed an engineering degree and founded a start-up before moving to the US for business school. Before joining Pepsi in 2012, he spent 19 years working as a consultant at McKinsey, where he advised large retail, healthcare and consumer goods companies on operations, strategies and dealmaking. Chris Sinclair, Reckitt’s chairman, said the board had considered about 60 candidates for the top post before selecting the company’s first outside leader since it was formed in 1999 from the merger of Reckitt & Colman of the UK and the Dutch company Benckiser.
- Financial Times•6 days ago
Reckitt’s new boss faces a Pepsi challenge
Last year, PepsiCo’s UK marketeers brought back “The Pepsi Challenge”: a blind tasting of its cola against the rival stimulant preferred by four out of five Britons (and, if I read the Sunday headlines correctly, at least two out of 10 candidates to be the next prime minister). the drinks group’s chief commercial officer, Laxman Narasimhan, as its new and first externally sourced chief executive. Rakesh Kapoor at the consumer goods group at a time when its margins — and share price — appear to have peaked.
- PR Newswire•6 days ago
PepsiCo Announces Senior Leadership Appointment
PURCHASE, N.Y., June 12, 2019 /PRNewswire/ -- PepsiCo, Inc. (NASDAQ: PEP) today announced that Ram Krishnan, currently Chief Executive Officer, Greater China for PepsiCo, has been appointed to the role of PepsiCo's Global Chief Commercial Officer. Krishnan will continue to lead PepsiCo's Greater China sector at this point.
- Zacks•7 days ago
Brown-Forman's (BF.B) Fords Gin Buyout to Enhance Portfolio
Brown-Forman (BF.B) agrees to buy The 86 Company, bringing the Fords Gin trademark to its growing portfolio of premium gins. This should fortify its strong spirits portfolio.
- Zacks•7 days ago
Top 5 ROE Stocks to Buy as US-Mexico Trade Concerns Abate
ROE helps investors distinguish profit-generating companies from profit burners and is useful in determining the financial health of a company.
- Markit•7 days ago
See what the IHS Markit Score report has to say about PepsiCo Inc.
PepsiCo Inc NASDAQ/NGS:PEPView full report here! Summary * Perception of the company's creditworthiness is negative * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for PEP with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting PEP. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold PEP had net inflows of $1.21 billion over the last one-month. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. PEP credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- PR Newswire•7 days ago
MTN DEW Introduces Sweet Lightning® Available Exclusively at KFC - A Bold New Beverage to Pair Perfectly with the Colonel's 11 Herbs and Spices
PURCHASE, N.Y., June 11, 2019 /PRNewswire/ -- Mountain Dew® and KFC® are partnering to electrify their beverage lineup with Sweet Lightning®, an out-of-this-sky refreshment lit up with a punch of peach and a touch of honey flavors. Available exclusively at KFC restaurants nationwide by July 1, DEW is fixin' up a true-to-its-roots soda that will brighten each and every one of your taste buds. With a "glass is always full" swagger, Sweet strolls into Colonel Sanders' office with his Southern charm and wins him over quicker than a bolt of lightning could strike! The Colonel and Sweet shook on it, agreeing that Sweet Lightning would not be served in any other restaurant, and one sweet deal was struck.
- Yahoo Finance•7 days ago
Analyst: Why the summer could help LaCroix stock's rediscover its fizz
Sales of LaCroix sparkling water have tumbled, but here's what could help revive the brand's fortunes.
- Zacks•8 days ago
PepsiCo (PEP) Gains But Lags Market: What You Should Know
PepsiCo (PEP) closed the most recent trading day at $133.59, moving +0.09% from the previous trading session.
- CorpGov.com•8 days ago
Take Stock in Children Palm Beach Executive Director: What a Nonprofit Needs from its Board Directors
Take Stock in Children Palm Beach Executive Director Nancy Stellway By John Jannarone Should governance at a nonprofit organization be different from a corporation like Microsoft, Amazon, or PepsiCo? The reality is that, aside from shareholder profits, organizations focused on social good actually need to consider many of the same issues faced by profit-focused corporations. […]
- Zacks•8 days ago
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
Sector ETF report for FSTA
- Insider Monkey•11 days ago
Did Hedge Funds Drop The Ball On PepsiCo, Inc. (PEP) ?
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge funds’ stock picking abilities to illustrate. The Standard and Poor’s 500 Index returned approximately 12.1% in 2019 (through May 30th). Conversely, hedge […]
- Zacks•11 days ago
Here's Why You Must Hold on to Molson Coors Stock Despite Woes
Molson Coors (TAP) witnesses soft volume in the United States and higher input costs resulting from tough industry conditions. But the company's premiumization and cost-saving efforts hold potential.
- InvestorPlace•11 days ago
Fundamentally Unsound New Age Beverages Stock Is Too Risky
If you're a contrarian in the cannabis space, you're likely very intrigued with New Age Beverages (NASDAQ:NBEV). Not only is the underlying plant one of the hottest commodities in the market, cannabis is going mainstream. A particularly attractive subsegment is cannabidiol or CBD-infused drinks. With New Age Beverages specializing in this sector, NBEV stock immediately catches the eye.Others have embraced the idea of CBD beverages. Canopy Growth (NYSE:CGC) and Hexo (NYSEAMERICAN:HEXO) have secured deals with big-time beverage makers. But as InvestorPlace feature writer James Brumley noted, NBEV was the first to hit the market. Almost always, that's better than being the first to have the idea. And with the competition lollygagging, NBEV launched the Marley brand last fall.InvestorPlace - Stock Market News, Stock Advice & Trading TipsSubsequently, NBEV stock soared from $1.53 to just under $10. That paradigm shift occurred over a matter of days. * The 10 Best Stocks for 2019 -- So Far But Brumley is cautious on the longer-term outlook for New Age Beverages stock, and for good reason. Management recently forked over some funds and possibly resources to acquire healthy-products maker Brands Within Reach. Supposedly, it's an "incredible deal." But to Brumley's point, we just don't know the specifics.That immediately raises suspicion. More critically, though, CBD-infused drinks are currently a tough sell. Although the concept is appealing, the retail market itself is filled to the brim with competitors. Plus, the market size is very modest.Investing heavily into this segment will seemingly yield very little reward. As such, investors took their profits and dumped NBEV stock after the announcement, with shares down 15% in the days since the June 3 announcement. To compare, the cannabis-focused ETFMG Alternative Harvest ETF (NYSEArca:MJ) is little changed while the beverage-heavy First Trust Consumer Staples AlphaDEX Fund (NYSEArca:FXG) is up almost 5% in the last few days. NBEV Stock is Fundamentally Stretched WideIn my view, New Age Beverages stock is an awkward play. Despite some obvious challenges, I believe in CBD-infused drinks for the long term.For one thing, the cat's out of the bag politically. In an unusually vitriolic time, both Republicans and Democrats have found surprising consensus in marijuana-related issues. While the federal government still classifies weed as a Schedule I drug, economic tensions also help the green sector in eventually overturning this classification.After all, President Trump can't keep playing hardball with China and Mexico without incurring domestic pain. And that translates into angry voters come 2020.Second, CBD specifically levers compelling evidence for medicinal effectiveness. Sure, medical doctors downplay this evidence because prescribing plants isn't exactly super-profitable. But they can't deny that many patients reported benefits with consuming CBD.Therefore, I'm willing to extend patience to names like Canopy Growth or Hexo. But NBEV stock? That's a tough one. If NBEV simply concentrated on cannabis-related products, I believe the investor community would give them considerable leeway. Cannabis is an unprecedented market, so it makes sense that it receives unprecedented flexibility.But NBEV stock isn't just a CBD competitor. Its acquisition of Brands Within Reach, which includes brands like Nestea and Evian, provides the proof. Instead, New Age Beverages seeks to dominate the broader healthy beverages market.In other words, NBEV has very normal ambitions. Because of that, investors will have normal expectations.One of those expectations is margins: prospective stakeholders will seek outsized profitability metrics. If you look at established beverage-makers like Coca-Cola (NYSE:KO), Pepsico (NASDAQ:PEP), or Monster Beverage (NASDAQ:MNST), they all feature strong margins.As a rule of thumb, beverage-makers should have on average higher margins than food companies. However, NBEV lags significantly in this department. No Outstanding Catalyst for NBEVAnother headwind I anticipate is that no outstanding catalyst bolsters the case for NBEV stock. I'm more convinced about this now after having looked at their website.Like any beverage company, NBEV has their core brands displayed front and center. The problem is, I'm not inspired by any of it. Nor have I heard of any of the brands they carry (outside their recent acquisition). * 10 Stocks to Buy That Could Be Takeover Targets Of course, my anecdotal observation isn't the end all, be all of anything. But I do a considerable amount of grocery shopping. Plus, I'm in the market for healthy beverages. If I can't recognize at least one of these brands, you gotta figure New Age Beverages stock has an uphill battle to climb.And this segues into my final point: I think NBEV stock has a credibility problem. They're competing in a very broad and saturated market. I'm not sure if they have the resources to withstand choppy waters that are surely coming.Although I like the CBD angle that New Age carries, I think there's too many questions. It might work out as a trade, but I'll be watching from the sidelines.As of this writing, Josh Enomoto did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 6 Retailers Including Disney Agree to Ditch On-Call Scheduling * The 10 Best Stocks for 2019 -- So Far * 7 Small-Cap ETFs to Buy Now Compare Brokers The post Fundamentally Unsound New Age Beverages Stock Is Too Risky appeared first on InvestorPlace.
- PR Newswire•13 days ago
Circulate Capital, U.S. Agency for International Development (USAID), and Ocean Conservancy Announce Blended Finance Partnership to Combat Ocean Plastic Pollution
USAID will guarantee up to $35 million of loans made by Circulate Capital to incentivize private capital investment and advance development objectives in the recycling value chain in South and Southeast ...
- Zacks•13 days ago
Brown-Forman (BF.B) Tops Q4 Earnings Estimates, Sales Lag
Brown-Forman's (BF.B) earnings beat estimates in fourth-quarter fiscal 2019, while sales missed estimates. The company provides robust view for fiscal 2020.
